HER-2 amplification is a relatively early event in the clinical pathogenesis of human breast cancer based on its frequent occurrence in the pre-invasive lesion, ductal carcinoma in situ (DCIS) [24-26]. The gene discussed is ERBB2; the disease is breast cancer.